FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
 HHS Logo links to Department of Health and Human Services website
Skip navigationFDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions
horizonal rule
Dockets Management

Up | AC Home Page

Food and Drug Administration

Cardiovascular and Renal Drugs Advisory Committee

September 21, 2006

 Briefing Information

Bayer Pharmaceuticals Corporation

NDA #20-304 TRASYLOL® (aprotinin injection) (pdf)

Disclaimer

The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

FDA

Briefing Document Prepared by the Division of Medical Imaging and Hematology Products
Office of Oncology Drug Products (pdf)

 

Page last updated September 20, 2006 kkhorizonal rule
Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA/Dockets Management